The U.S. Food and Drug Administration (FDA) has cleared proton therapy developer ProTom International's Radiance 330 single-room proton therapy system.
The system, installed at Massachusetts General Hospital in Boston, can be sited within a vault space of 20 x 30 ft and requires 40% less radiation shielding than conventional proton therapy systems, according to the firm.
